Skip to main content

Advertisement

SpringerLink
Log in

Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zhang Y, Ji Y, Li J et al (2018) Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival. Breast Cancer Res Treat 168:679–686. https://doi.org/10.1007/s10549-018-4660-y

    Article  PubMed  CAS  Google Scholar 

  2. Regan MM, Walley BA, Francis PA et al (2017) Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT. Ann Oncol 28:2225–2232. https://doi.org/10.1093/annonc/mdx285

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Lambertini M, Moore HCF, Leonard RCF et al (2018) Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data. J Clin Oncol. https://doi.org/10.1200/JCO.2018.78.0858

    Article  PubMed  Google Scholar 

  4. Oktay K, Harvey BE, Partridge AH et al (2018) Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. https://doi.org/10.1200/JCO.2018.78.1914

    Article  PubMed  Google Scholar 

  5. Paluch-Shimon S, Pagani O, Partridge AH et al (2017) ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast 35:203–217. https://doi.org/10.1016/j.breast.2017.07.017

    Article  PubMed  Google Scholar 

  6. Lambertini M, Cinquini M, Moschetti I et al (2017) Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology. Eur J Cancer 71:25–33. https://doi.org/10.1016/j.ejca.2016.10.034

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo, 121, 1000, Brussels, Belgium

    Francesca Poggio & Matteo Lambertini

  2. Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino, University of Genova, Genova, Italy

    Francesca Poggio & Benedetta Conte

  3. Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium

    Matteo Lambertini

Authors
  1. Francesca Poggio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benedetta Conte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matteo Lambertini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matteo Lambertini.

Ethics declarations

Conflict of interest

Matteo Lambertini acknowledges the support from the European Society for Medical Oncology (ESMO) for a Translational Research Fellowship at Institut Jules Bordet, Brussels, Belgium, and he served as a consultant for Teva outside the submitted work. The other authors declare no conflict of interest in relation to this article.

Ethical approval

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poggio, F., Conte, B. & Lambertini, M. Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy. Breast Cancer Res Treat 171, 245–246 (2018). https://doi.org/10.1007/s10549-018-4806-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-018-4806-y

Search

Navigation